We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Santhera Receives FDA Fast Track Designation for Raxone®/Catena®

News   Apr 10, 2015

 
Santhera Receives FDA Fast Track Designation for Raxone®/Catena®
 
 
 

RELATED ARTICLES

Obesity & Vitamin D Deficiency May Indicate Greater Breast Cancer Risk

News

New study demonstrates that postmenopausal women have an increased risk of vitamin D deficiency at the time of breast cancer diagnosis, associated with a higher rate of obesity.

READ MORE

Experimental Nasal Influenza Vaccine Tested in Kids, Teens

News

NIH-supported Phase 1 trial of potential broadly protective vaccine.

READ MORE

Gout Get Outta Here

News

Researchers found a significant reduction in risk of gout attacks among patients who received the drug (canakinumab) that targets a key inflammatory molecule, suggesting a new target for therapeutic strategies to prevent gout attacks.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE